SecBot SecBot
DEFA14A ·Filed Apr 20, 2026

RDNT

RadNet, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed7mo ago SEC0001683168-26-003087
Proxy solicitation materials
Actionable Insight • Neutral

The filing is a standard proxy statement for an annual meeting. Monitor the shareholder vote results for the equity incentive plan amendment, as approval could lead to future share dilution.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$57.51
T+0 close · Apr 20, 2026 · via day close
Latest settled
+9.53%
T+60 · $62.99
Vs SPY
+2.63%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 21 $57.51entry
  2. T+1 · 7mo ago +0.56%α −0.46% · $57.83
  3. T+5 · 7mo ago +0.66%α −0.42% · $57.89
  4. T+20 · 6mo ago −5.81%α −10.72% · $54.17
  5. T+60 · 4mo ago +9.53%α +2.63% · $62.99
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

RadNet, Inc. filed its definitive proxy statement (DEFA14A) for its 2026 Annual Meeting, outlining the board's recommendations for the election of directors, ratification of auditors, approval of executive compensation, and an amendment to its equity incentive plan.

Key Financial Metrics

Vote
director election
Meeting
2026-06-02
Seats Contested
6

Key Facts

  • Company: RadNet, Inc. (RDNT)
  • Filing Type: DEFA14A (Definitive Additional Materials)
  • Meeting Date: June 2, 2026
  • Proposals: 1) Election of 6 directors, 2) Ratification of Ernst & Young LLP as auditors, 3) Advisory vote on executive compensation, 4) Approval of an amendment to the Equity Incentive Plan

Financial Impact

No immediate financial impact; routine governance filing.

dilution

Risk Factors

  • Shareholder dissent on executive compensation or the equity plan amendment could lead to a negative vote, potentially impacting executive morale or retention.
  • Failure to ratify auditors could signal a significant governance issue, though this is highly unlikely.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001683168-26-003087
Document: 0001683168-26-003087-index.html0001683168-26-003087
Document: 0001683168-26-003087.txt0001683168-26-003087

US Market Status

Market Closed · Opens Wed (12h 13m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 20, 2026